Laimei Pharmaceutical: Announcement on participating in the 2024 Online Investor Group Reception Day for Listed Companies in Chongqing
Laimei Pharmaceuticals: Announcement on the proposed change of accounting firm
Laimei Pharmaceuticals: Announcement on providing a guarantee extension for the loan of the participating company Condesay
Laimei Pharmaceutical: Announcement of Resolutions of the 40th Meeting of the Fifth Board of Directors
Laimei Pharmaceutical: Announcement of Resolutions of the 34th Meeting of the Fifth Board of Supervisors
Laimei Pharmaceutical: Announcement on obtaining a drug registration certificate
Laimei Pharmaceuticals: “Internal Audit System” (October 2024)
Laimei Pharmaceutical: Announcement of Resolutions of the 33rd Meeting of the Fifth Board of Supervisors
Laimei Pharmaceutical: Announcement on deposit business and related transactions with Guangxi Beibu Gulf Bank Co., Ltd.
Laimei Pharmaceutical: Announcement on providing a guarantee for the financing and credit of Chongqing Laimei Longyu Pharmaceutical Co., Ltd.
Laimei Pharmaceutical: Announcement of Resolutions of the 39th Meeting of the Fifth Board of Directors
Chongqing Lummy Pharmaceutical: Announcement Regarding the Application for Credit Limit for Financial Leasing Business to Far East International Financial Leasing Co., Ltd.
Chongqing Lummy Pharmaceutical: Board of directors resolution announcement.
Chongqing Lummy Pharmaceutical: Announcement regarding the confirmation of daily related transactions in the first half of 2024 and the expected daily related transactions in the second half of 2024.
Chongqing Lummy Pharmaceutical: Announcement regarding providing guarantee for financing credit to Chongqing Lai Meilongyu Pharmaceutical Co., Ltd.
Chongqing Lummy Pharmaceutical: Announcement of the Supervisory Board's resolution.
Chongqing Lummy Pharmaceutical: Opinions from the first independent director's special meeting review in 2024.
Chongqing Lummy Pharmaceutical: Announcement regarding obtaining pharmaceutical registration certificate.
Laimei Pharmaceuticals: 300006 Laimei Pharmaceuticals Investor Relations Management Information 20240403
Laimei Pharmaceutical: Announcement on participating companies obtaining approval notices for drug clinical trials
No Data